Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Regeneron Pharmaceuticals Inc. for $15.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Regeneron Pharmaceuticals Inc. pages available today for free:

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Beginner level

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

Microsoft Excel LibreOffice Calc
ROE = ROA × Financial Leverage
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×
Dec 31, 2018 = ×
Sep 30, 2018 = ×
Jun 30, 2018 = ×
Mar 31, 2018 = ×
Dec 31, 2017 = ×
Sep 30, 2017 = ×
Jun 30, 2017 = ×
Mar 31, 2017 = ×
Dec 31, 2016 = ×
Sep 30, 2016 = ×
Jun 30, 2016 = ×
Mar 31, 2016 = ×
Dec 31, 2015 = ×
Sep 30, 2015 = ×
Jun 30, 2015 = ×
Mar 31, 2015 = ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in return on equity ratio (ROE) over Q2 2020 is the increase in profitability measured by return on assets ratio (ROA).

Three-Component Disaggregation of ROE

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

Microsoft Excel LibreOffice Calc
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×
Dec 31, 2018 = × ×
Sep 30, 2018 = × ×
Jun 30, 2018 = × ×
Mar 31, 2018 = × ×
Dec 31, 2017 = × ×
Sep 30, 2017 = × ×
Jun 30, 2017 = × ×
Mar 31, 2017 = × ×
Dec 31, 2016 = × ×
Sep 30, 2016 = × ×
Jun 30, 2016 = × ×
Mar 31, 2016 = × ×
Dec 31, 2015 = × ×
Sep 30, 2015 = × ×
Jun 30, 2015 = × ×
Mar 31, 2015 = × ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in return on equity ratio (ROE) over Q2 2020 is the increase in profitability measured by net profit margin ratio.

Five-Component Disaggregation of ROE

Regeneron Pharmaceuticals Inc., decomposition of ROE (quarterly data)

Microsoft Excel LibreOffice Calc
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Jun 30, 2020 = × × × ×
Mar 31, 2020 = × × × ×
Dec 31, 2019 = × × × ×
Sep 30, 2019 = × × × ×
Jun 30, 2019 = × × × ×
Mar 31, 2019 = × × × ×
Dec 31, 2018 = × × × ×
Sep 30, 2018 = × × × ×
Jun 30, 2018 = × × × ×
Mar 31, 2018 = × × × ×
Dec 31, 2017 = × × × ×
Sep 30, 2017 = × × × ×
Jun 30, 2017 = × × × ×
Mar 31, 2017 = × × × ×
Dec 31, 2016 = × × × ×
Sep 30, 2016 = × × × ×
Jun 30, 2016 = × × × ×
Mar 31, 2016 = × × × ×
Dec 31, 2015 = × × × ×
Sep 30, 2015 = × × × ×
Jun 30, 2015 = × × × ×
Mar 31, 2015 = × × × ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in return on equity ratio (ROE) over Q2 2020 is the increase in operating profitability measured by EBIT margin ratio.

Two-Component Disaggregation of ROA

Regeneron Pharmaceuticals Inc., decomposition of ROA (quarterly data)

Microsoft Excel LibreOffice Calc
ROA = Net Profit Margin × Asset Turnover
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×
Dec 31, 2018 = ×
Sep 30, 2018 = ×
Jun 30, 2018 = ×
Mar 31, 2018 = ×
Dec 31, 2017 = ×
Sep 30, 2017 = ×
Jun 30, 2017 = ×
Mar 31, 2017 = ×
Dec 31, 2016 = ×
Sep 30, 2016 = ×
Jun 30, 2016 = ×
Mar 31, 2016 = ×
Dec 31, 2015 = ×
Sep 30, 2015 = ×
Jun 30, 2015 = ×
Mar 31, 2015 = ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in return on assets ratio (ROA) over Q2 2020 is the increase in profitability measured by net profit margin ratio.

Four-Component Disaggregation of ROA

Regeneron Pharmaceuticals Inc., decomposition of ROA (quarterly data)

Microsoft Excel LibreOffice Calc
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Jun 30, 2020 = × × ×
Mar 31, 2020 = × × ×
Dec 31, 2019 = × × ×
Sep 30, 2019 = × × ×
Jun 30, 2019 = × × ×
Mar 31, 2019 = × × ×
Dec 31, 2018 = × × ×
Sep 30, 2018 = × × ×
Jun 30, 2018 = × × ×
Mar 31, 2018 = × × ×
Dec 31, 2017 = × × ×
Sep 30, 2017 = × × ×
Jun 30, 2017 = × × ×
Mar 31, 2017 = × × ×
Dec 31, 2016 = × × ×
Sep 30, 2016 = × × ×
Jun 30, 2016 = × × ×
Mar 31, 2016 = × × ×
Dec 31, 2015 = × × ×
Sep 30, 2015 = × × ×
Jun 30, 2015 = × × ×
Mar 31, 2015 = × × ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in return on assets ratio (ROA) over Q2 2020 is the increase in operating profitability measured by EBIT margin ratio.

Disaggregation of Net Profit Margin

Regeneron Pharmaceuticals Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel LibreOffice Calc
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×
Dec 31, 2018 = × ×
Sep 30, 2018 = × ×
Jun 30, 2018 = × ×
Mar 31, 2018 = × ×
Dec 31, 2017 = × ×
Sep 30, 2017 = × ×
Jun 30, 2017 = × ×
Mar 31, 2017 = × ×
Dec 31, 2016 = × ×
Sep 30, 2016 = × ×
Jun 30, 2016 = × ×
Mar 31, 2016 = × ×
Dec 31, 2015 = × ×
Sep 30, 2015 = × ×
Jun 30, 2015 = × ×
Mar 31, 2015 = × ×

Based on: 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-05), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-07), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-11-08), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-04), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-05), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-07).

The primary reason for the increase in net profit margin ratio over Q2 2020 is the increase in operating profitability measured by EBIT margin ratio.